×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
IVVD – invivyd, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
IVVD
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/5
08:11 am
ivvd
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Medium
Report
Invivyd, Inc. (NASDAQ: IVVD) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
3/5
07:05 am
ivvd
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
Low
Report
Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1
2/28
08:02 pm
ivvd
Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart) [Yahoo! Finance]
High
Report
Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart) [Yahoo! Finance]
2/28
08:02 pm
ivvd
Invivyd Doses First Participants in Phase 1 Clinical Trial of VYD2311, a Next Generation Monoclonal Antibody Candidate for COVID-19, Building on the Success of PEMGARDA™ [Yahoo! Finance]
High
Report
Invivyd Doses First Participants in Phase 1 Clinical Trial of VYD2311, a Next Generation Monoclonal Antibody Candidate for COVID-19, Building on the Success of PEMGARDA™ [Yahoo! Finance]
2/28
08:02 pm
ivvd
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024 [Yahoo! Finance]
High
Report
Invivyd to Present PEMGARDA™ (pemivibart) Data at Infectious Disease Week (IDWeek) 2024 [Yahoo! Finance]
2/28
02:06 pm
ivvd
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024 [Yahoo! Finance]
Medium
Report
Invivyd to Host Third Quarter 2024 Financial Results and Corporate Update Conference Call on November 14, 2024 [Yahoo! Finance]
2/27
09:58 am
ivvd
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to Med
Low
Report
Invivyd Announces Preprints Conveying CANOPY Phase 3 Clinical Trial Data Including Long-Term Protection Versus Recent JN.1 Sublineages at Low Residual Titers, and Describing a Novel Approach for Predicting Monoclonal Antibody Activity Were Uploaded to Med
2/26
06:28 am
ivvd
Chargers' Jim Harbaugh loves seeing NFL stars being open about their faith: 'It's inspiring' [FOX News]
Medium
Report
Chargers' Jim Harbaugh loves seeing NFL stars being open about their faith: 'It's inspiring' [FOX News]
Date
Time
Symbol
Headline
Impact
3/5
07:11 am
ivvd
Form 8-K Invivyd, Inc. For: Mar 05
High
Report
Form 8-K Invivyd, Inc. For: Mar 05
2/24
07:12 am
ivvd
Form 8-K Invivyd, Inc. For: Feb 21
Low
Report
Form 8-K Invivyd, Inc. For: Feb 21
2/19
04:32 pm
ivvd
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Andersen Jill
High
Report
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Andersen Jill
2/19
04:30 pm
ivvd
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Green Julie
High
Report
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Green Julie
2/19
04:30 pm
ivvd
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Lee Timothy Edward
High
Report
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Lee Timothy Edward
2/19
04:30 pm
ivvd
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Allen Robert D. III
High
Report
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Allen Robert D. III
2/19
04:30 pm
ivvd
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Duke William E.
High
Report
Form 4 Invivyd, Inc. For: Feb 15 Filed by: Duke William E.
2/12
09:20 am
ivvd
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Invivyd, Inc. Filed by: FMR LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: